Previous Article | Next Article ![]()
Infect Immun, March 1998, p. 987-993, Vol. 66, No. 3
Departments of
Medicine1 and
Microbiology and
Immunology,2 School of Medicine, University
of North Carolina, Chapel Hill, North Carolina 27599
Received 8 October 1997/Returned for modification 10 December
1997/Accepted 30 December 1997
Most Neisseria gonorrhoeae isolates are unable to use
human hemoglobin as the sole source of iron for growth
(Hgb Mammalian hosts use iron-binding
proteins and iron-sequestering compounds to maintain free iron at a
level that is too low for the growth of invading bacterial pathogens
(52). Several pathogenic organisms have developed specific
mechanisms for iron acquisition which are induced under conditions of
iron limitation. The genital mucosal pathogen Neisseria
gonorrhoeae is known to use iron from lactoferrin and transferrin
for growth (37, 38). The ability to use lactoferrin and
transferrin is due to specific receptors (reviewed in reference
11). Gonococci also are able to utilize heme and
certain heme-containing proteins as iron sources (15, 38).
Two heme-binding proteins (99 and 44 kDa) have been isolated from the
total membranes of gonococcal clinical isolates grown under
iron-limited conditions (26, 29). Nevertheless, the
mechanism of iron uptake from heme-containing proteins is unclear.
Mickelsen and Sparling (38) showed that 18 of 29 gonococcal
strains studied were capable of using hemoglobin for growth. Lee and
Hill (28) detected hemoglobin binding activity from Neisseria meningitidis grown under iron-limited conditions.
More recently, two different meningococcal hemoglobin receptors have been described at the molecular level. Stojiljkovic et al. (49, 50) cloned a gene encoding an iron-regulated outer membrane protein, HmbR, which has amino acid similarity with the family of
TonB-dependent membrane receptors. Lewis and Dyer (30) and Lewis et al. (31) described hpuAB, the
hemoglobin-haptoglobin utilization operon of N. meningitidis, and suggested that HpuA and HpuB constitute a
two-component receptor analogous to the bipartite transferrin receptor
TbpB-TbpA (formerly named Tbp2-Tbp1) (reviewed in reference
11). Predicted amino acid sequences of N. meningitidis HpuA and HpuB indicate that, like TbpB and TbpA, HpuB
belongs to the TonB-dependent family of high-affinity transport proteins and HpuA is probably a lipoprotein (31).
We previously reported that all tested gonococcal strains can use
hemoglobin as a sole source of iron for growth by switching from a
non-hemoglobin-utilizing phenotype (Hgb Bacterial strains and growth conditions.
N.
gonorrhoeae strains used are listed in Table
1. Both Hgb+ and
Hgb
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Phase Variation of Hemoglobin Utilization in
Neisseria gonorrhoeae
![]()
ABSTRACT
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
), but a minor population is able to do so
(Hgb+). This minor population grows luxuriously on
hemoglobin, expresses two outer membrane proteins of 42 kDa (HpuA) and
89 kDa (HpuB), and binds hemoglobin under iron-stressed conditions. In
addition to the previously reported HpuB, we identified and
characterized HpuA, which is encoded by the gene hpuA,
located immediately upstream of hpuB. Expression of both
proteins was found to be controlled at the translational level by
frameshift mutations in a run of guanine residues within the
hpuA sequence encoding the mature HpuA protein. The
"on-phase" hemoglobin-utilizing variants contained 10 G's, while
the "off-phase" variants contained 9 G's. Insertional hpuB mutants of FA19 Hgb+ and FA1090
Hgb+ no longer expressed HpuB but still produced HpuA. A
polar insertional mutation of the upstream hpuA gene in
FA1090 Hgb+ eliminated production of both HpuA and HpuB,
whereas a nonpolar insertional mutant expressed HpuB only. Insertional
mutagenesis of either hpuA or hpuB or both
substantially decreased the hemoglobin binding ability of the FA1090
Hgb+ variant and prevented growth on hemoglobin plates.
Therefore, both HpuA and HpuB were required for the utilization of
hemoglobin for growth.
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
) to a
hemoglobin-utilizing phenotype (Hgb+) in vitro. In order to
distinguish these two phenotypes of the same strain, we classified
gonococci able to grow on hemoglobin-Desferal plates as
Hgb+ variants and those unable to grow on
hemoglobin-Desferal plates as Hgb
variants
(8). The ability to use hemoglobin for growth appears to be
a phase-varying phenomenon, because Hgb+ variants arise
from Hgb
parents at a frequency of about 1 × 10
4 to 2 × 10
3 (8). In
this communication, we describe the mechanism underlying the phase
variation of hemoglobin utilization and the characteristics of a 42-kDa
HpuA protein encoded by the gonococcal hpuA gene. We also
previously reported that insertional mutants that no longer expressed
the 89-kDa HpuB protein cannot utilize hemoglobin to support growth but
still grow on heme (8). Now we report on the requirement for
HpuA in the utilization of hemoglobin for growth by N. gonorrhoeae.
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
variants of FA1090 and FA19 were used. Growth
conditions were the same as those described by Chen et al.
(8), with the exception that the iron chelator Desferal
(deferoxamine mesylate; CIBA Pharmaceutical Co.) was used at a 100 µM
final concentration for FA1090 and insertional mutants of FA1090. The
abilities of FA1090 Hgb
and Hgb+ variants and
their hpuA and/or hpuB insertional mutants to
grow on heme were tested on modified gonococcal medium base (GCB) agar plates (8) containing bovine hemin chloride (Sigma) at 5 mg/liter and Desferal at 100 µM. Antibiotic selection in gonococci
employed erythromycin at 1 mg/liter for mini-Tn3erm
insertions (30), spectinomycin at 100 mg/liter for the
interposon insertions (44), and kanamycin at 60 mg/liter for
the aphA-3 cassette insertions (35).
TABLE 1.
Bacterial strains and plasmids used in this study
Sequencing the gonococcal hpuA gene.
Double-stranded PCR products, purified with a Geneclean II kit (Bio
101, Inc.), were sequenced directly. Chromosomal DNAs of FA1090
Hgb+ and FA1090 Hgb
were used as templates
for PCRs. Initially, the putative open reading frame of FA1090
hpuA was identified from the database of the Gonococcal
Genome Sequencing Project (Advanced Center for Genome Technology,
University of Oklahoma) by searching for the coding sequence of the N
terminus of FA1090 HpuB (8). The 19-mer upstream PCR primer
(hpu.01, GCAGGCACGTCCGATTTCC) was designed based on the
sequence 108 bp upstream of the ATG codon of the putative
hpuA open reading frame (Fig.
1). A 20-mer downstream primer (hpu.14,
ACAAAACCCAAAAACTCGGAC) was designed, based on the N-terminal
amino acid sequence of HpuB, to generate PCR DNA fragments covering the
entire hpuA gene (Fig. 1). Two PCRs were carried out for
each variant. One used purified chromosomal DNA, and the other used
boiled cells, as the template. PCR products were pooled for sequencing.
Both strands of the PCR-generated hpuA DNA were sequenced by
using hpu.01, hpu.14, and four additional internal primers.
|
variants and of 440 bp from Hgb+
variants. Sequencing of PCR-generated partial FA1090 hpuA
fragments was carried out on both strands with primers hpu.01 and
hpu.02. Sequencing of PCR-generated partial FA19 hpuA
fragments was carried out on single strands only.
Oligonucleotides were synthesized at the Lineberger Comprehensive
Cancer Center DNA Synthesis Facility of the University of North
Carolina
Chapel Hill. DNA sequencing was carried out at the Automated
DNA Sequencing Facility of the University of North Carolina
Chapel
Hill with an Applied Biosystems model 373 DNA sequencer by use of the
Tag DyeDeoxy Terminator Cycle Sequencing kit (Applied Biosystems).
Cloning of the hpuA gene.
Routine molecular
cloning techniques as described by Sambrook et al. (47) were
used. Plasmid DNAs were isolated by either the Wizard Minipreps DNA
purification system (Promega) or the Qiagen DNA purification system.
Chromosomal DNA from N. gonorrhoeae was purified by the
method of Stern et al. (48). The 1,360-bp PCR DNA made from
the FA1090 Hgb
template and the 1,361-bp PCR DNA made
from the FA1090 Hgb+ template were inserted into the pCRII
vector by using the TA cloning kit (Invitrogen) to yield pUNCH258 and
pUNCH259, respectively.
Insertional mutagenesis of the hpuA gene. (i)
Construction of polar hpuA insertional mutants.
In
order to avoid potential variations in the poly(G) region during
experimental manipulation of hpuA, insertional mutagenesis of hpuA was carried out within a
NarI-XbaI fragment isolated from pUNCH258 (Fig.
1). The NarI site was located 108 bp downstream of the
poly(G) tract, and the XbaI site was present in the
polylinker of pCRII. The NarI-XbaI fragment was
subcloned into the pBluescript II KS+ phagemid (Stratagene)
digested with XbaI-AccI to yield pUNCH260. In
order to avoid blocking of PpuMI digestion by Dcm methylase activity, pUNCH260 was moved from Escherichia coli DH5
MCR
(Bethesda Research Laboratories) to GM2163 (New England Biolabs). The
2-kb
interposon fragment isolated from SmaI-cut pHP45
(44) was ligated with pUNCH260, digested with
PpuMI, and filled in with the Klenow fragment of DNA
polymerase I (Fig. 1) to yield pUNCH268. pUNCH268, containing an
insert in the hpuA fragment, was then transformed into
FA1090 Hgb
and FA1090 Hgb+ to generate FA6981
and FA6982, respectively. Transformant colonies were screened for
resistance to spectinomycin at 100 mg/liter and the inability to grow
on hemoglobin-Desferal plates.
(ii) Construction of a nonpolar hpuA insertional mutant. A mutagenic cassette designed to be inserted into a gene of an operon without affecting transcription of downstream genes (35) was adopted for our construction of a nonpolar hpuA mutant. The 800-bp aphA-3 insert cassette was isolated from pUC18K by SmaI digestion (35) and was ligated to PpuMI-digested pUNCH260 to generate pUNCH271. pUNCH271 was then transformed into FA1090 Hgb+ to create FA6983. Transformant colonies were screened for resistance to kanamycin at 60 mg/liter and the inability to grow on hemoglobin-Desferal plates.
Enumeration of G residues. The cloned hpuA gene in pUNCH258 and pUNCH259 was sequenced with M13 reverse primer (Invitrogen). The guanine residues in hpuA from FA6981, FA6982, and FA6983 were enumerated from PCR products generated by the primer pair hpu.01 and hpu.02 in order to confirm that gonococcal transformants containing the mutagenized fragment of hpuA kept the same number of guanine residues in the poly(G) tract as was present in the parents. Primer hpu.01 was used in sequencing those partial hpuA fragments from mutants.
DNA hybridization.
Southern blots were utilized to confirm
that allelic exchange occurred as expected. Chromosomal DNAs of FA1090
Hgb
, FA1090 Hgb+, and hpuA or
hpuB insertional mutants of FA1090 Hgb+ (FA6982,
FA6983, and FA6929) were digested with ClaI and separated on
0.7% agarose gels. Gels were transferred bidirectionally to Magnagraph
nylon membranes (Micron Separations). Blots were probed, as described
in Results, with random-primed digoxigenin-dUTP-labeled DNA and were
developed according to the Genius labeling and detection instructions
(Boehringer Mannheim Biochemicals).
Peptide synthesis and immunization. A 20-mer peptide was designed based on the predicted strong antigenicity of the last 17 amino acids of the C terminus of HpuA (CGG-EKKLDDTSQDTNHLTKQ). Another peptide (CGG-ADPAPQSAQTLN) was designed previously based on the N-terminal amino acid sequence of HpuB (8). Peptide synthesis was performed at the University of North Carolina Program in Molecular Biology and Biotechnology MicroProtein Chemistry Facility with a multiple peptide synthesizer (Rainin Symphony). Peptide synthesis and immunization followed the procedures described by Elkins (16) and Chen et al. (8).
Affinity purification of antibodies raised against the N-terminal peptide of HpuB and the C-terminal peptide of HpuA. Postimmune antipeptide sera for HpuB (8) and HpuA were each affinity purified to eliminate reactivity to antigens other than HpuA and HpuB. A modification of a previously published method as reported by Elkins et al. (17) was used for the affinity purification of antipeptide antibodies on immobilized peptide coupled on thiopropyl-agarose columns (Sigma) (42).
Preparations of whole-cell dot blots and outer membranes from
gonococci grown under iron-replete and iron-stressed conditions.
Gonococci were grown in iron-sufficient and iron-limited media.
Gonococcal medium broth containing Kellogg's supplement I was
inoculated from overnight plate-grown gonococcal cultures (Hgb
on GCB plates and Hgb+ on
hemoglobin-Desferal plates). After one mass doubling, cultures were
split. Desferal was added to a 100 µM concentration to induce iron
starvation in one flask, whereas supplement II (ferric nitrate at 12 µM) was added to the other flask. After 4 h of growth with either the chelator or the iron supplement, cells were harvested by
centrifugation. The density of harvested cells was adjusted to an
optical density of 0.2 at 600 nm (approximately 2 × 108 CFU/ml) with phosphate-buffered saline. Dot blots were
prepared from wells loaded with 100 µl of the adjusted cell
suspensions. Total membranes and outer membranes were prepared as
previously described (16). The protein content was
determined by a bicinchoninic acid assay (Pierce).
Purification of hemoglobin-binding proteins from total membranes. Purification of hemoglobin-binding proteins used bovine hemoglobin-agarose (chromatography specialty resin) supplied by Sigma. Purification with solid-phase hemoglobin-agarose followed a procedure described by Elkins (16). Hemoglobin-binding proteins were eluted in Laemmli sample buffer for analytical sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and Western blotting (immunoblotting).
Whole-cell dot blot hemoglobin binding assay. FA1090 Hgb+, FA6929, and hpuA insertional mutants of FA1090 Hgb+ (FA6982 and FA6983) were examined for their ability to bind hemoglobin in a whole-cell dot blot assay. Human hemoglobin was biotinylated with N-hydroxysuccinimide-SS-Biotin (21331D; Pierce) according to the manufacturer's instructions at a molar ratio of 23:1 at 4°C for 2 h. The unbound biotin was removed by dialysis overnight in phosphate-buffered saline at 4°C. The binding was detected by a colorimetric procedure using alkaline phosphatase-conjugated streptavidin (Pierce) as the secondary reagent.
Western blot analysis of membrane proteins. SDS-PAGE and Western blotting of total membrane proteins, outer membrane proteins, and hemoglobin-binding proteins purified from total membranes were performed as described by Harlow and Lane (20). One nitrocellulose membrane each was prepared for Western blotting of total membrane, outer membrane, and hemoglobin-binding proteins. These membranes were cut into upper and lower panels along a line drawn between 55 and 60 kDa. The upper panels were probed with affinity-purified serum raised against the N-terminal peptide of HpuB (8), and the lower panels were probed with affinity-purified serum raised against the C-terminal peptide of HpuA.
| |
RESULTS |
|---|
|
|
|---|
Gonococcal hpuA gene.
We obtained the sequence of
hpuA from both FA1090 Hgb
and FA1090
Hgb+ by sequencing PCR products of the primer pair hpu.01
and hpu.14 directly. Data containing DNA sequence of FA1090
hpuA have been released incrementally by the N. gonorrhoeae Genome Sequencing Project. The sequence identical to
our FA1090 Hgb
hpuA sequence was released as
part of the February 1997 update. Since the sequence of the FA1090
hpuAB operon is now readily available from the database of
the project (the University of Okalahoma's Advanced Center for Genome
Technology at http://www.dna1.chem.uoknor.edu) and from GenBank
(accession no. AF031495), the hpuA sequence is not listed in
detail in this communication.
variant and the
Hgb+ variant. PCR products from FA19 Hgb
and
FA19 Hgb+, two reactions each, also contained 9 G's for
the nonhemoglobin-utilizing variant and 10 G's for the
hemoglobin-utilizing variant. Since the number of G's in both strains
was consistent for the respective variants, the difference in numbers
was variant specific and not the result of PCR error. Deletion of 1 G
from the 10-G poly(G) tract resulted in a frame shift in the coding
sequence for HpuA and led to an immediate stop codon (Fig. 1). Thus,
changes in the expression states of hpuA involved an altered
reading frame register and resulted in switches between the "on
phase" and the "off phase" of hemoglobin utilization.
PCR clones and insertional mutants of hpuA.
Curiously,
pUNCH258 and pUNCH259, which were plasmids containing cloned
hpuA from FA1090 Hgb
and FA1090
Hgb+, respectively, both contained 9 G's in the poly(G)
tract. It seems that reversion had occurred in the E. coli
transformation of pUNCH259 and that the selection was skewed to clones
containing 9 G's. Insertional mutagenesis of FA1090 Hgb+
resulted in hpuB mutant FA6929 (8) and
hpuA mutants FA6982 and FA6983. All three mutants contained
10 G's in the poly(G) tract, whereas the hpuA insertional
mutant of FA1090 Hgb
, FA6981, contained 9 G's. Thus,
gonococcal transformation with a fragment of hpuA containing
either the
interposon or the aphA-3 cassette did not
alter the poly(G) region. Changes in hemoglobin utilization phenotypes
of these transformants reflected changes that resulted from insertional
inactivation of the hpuA and/or the hpuB alleles.
Southern blot analysis of hpuA insertional
mutants.
In order to confirm that each mutant had the appropriate
insertion, Southern blotting was performed with three separate DNA probes. One was an 850-bp hpuB fragment of the
EcoRI digest of the plasmid pSM85k (30). The
other two were the DNA fragments of SmaI-cut
interposon
(2,082 bp) and SmaI-cut aphA-3 cassette (787 bp).
When chromosomal DNA from either FA1090 Hgb
or FA1090
Hgb+ was digested with ClaI, the hpuB
probe hybridized with a DNA fragment of roughly 8 kb. In FA6929,
FA6982, or FA6983, the same probe hybridized with fragments of
approximately 9 to 10 kb. Due to the large sizes of
ClaI-digested fragments, exact sizes of labeled fragments
were hard to estimate; nevertheless, sizes of fragments from the
mutants were appropriately larger than the size of the fragment from
the parent (Fig. 2, upper panel). The
probe hybridized with FA6982 DNA only (Fig. 2A, lower panel), and the
aphA-3 probe hybridized with FA6983 DNA only (Fig. 2B, lower
panel), at the appropriate size positions as predicted.
|
Localization of the HpuA protein. Expression of both HpuA and HpuB was iron regulated. While HpuB could be detected in stained gels of whole-cell lysates, total membrane proteins, outer membrane proteins, or hemoglobin-binding proteins (8), HpuA was not readily visible in the Coomassie-stained gels, the silver-stained (51) gels, or autoradiographs of iodinated membrane protein gels (data not shown). However, Western blotting with affinity-purified antibody raised against the C-terminal peptide of HpuA revealed an iron stress-induced 42-kDa band in whole cells (data not shown) and membrane preparations. This band appeared along with the 89-kDa HpuB in iron-stressed FA1090 Hgb+ (Fig. 3A and B, lanes 2) and FA19 Hgb+ (data not shown) but was absent in the hpuA insertional mutants FA6982 and FA6983 (Fig. 3A and B, lanes 6 and 8). The HpuA of hemoglobin-utilizing variants could be affinity purified from total membrane proteins with immobilized hemoglobin (Fig. 3C, lane 2).
|
Expression of HpuA and HpuB in mutants.
Since we were unable
to identify any consensus promoter sequence for hpuB, it was
expected that insertional mutation of the upstream hpuA with
the
interposon would prevent expression of both HpuA and HpuB. On
the other hand, since the aphA-3 gene is preceded by
translation stop codons in all three reading frames and is followed by
a consensus ribosome binding site and a start codon (35), it
was expected that successful insertion of the aphA-3
cassette in hpuA would prevent expression of HpuA but not of
HpuB.
Hemoglobin binding and utilization of hpuA insertional
mutants.
Iron-stressed, hemoglobin-utilizing FA1090
Hgb+ bound biotinylated human hemoglobin in a whole-cell
dot blot assay (Fig. 4). The binding was
inhibited by excess unlabeled hemoglobin but not by excess hemin at a
molar ratio of 100:1 (data not shown). The hpuB insertional
mutant, FA6929, and the polar and nonpolar hpuA insertional
mutants, FA6982 and FA6983, all demonstrated impaired binding of
biotinylated hemoglobin (Fig. 4). None of the hpuA or
hpuB mutants of FA1090 Hgb+ (FA6929
[HpuA+ HpuB
], FA6982 [HpuA
HpuB
], or FA6983 [HpuA
HpuB+]) was able to grow on modified GCB plates using
human hemoglobin as the sole iron source (Fig.
5). Nevertheless, all three mutants and
both FA1090 Hgb
and FA1090 Hgb+ grew well on
modified GCB plates containing hemin (data not shown).
|
|
| |
DISCUSSION |
|---|
|
|
|---|
In order to examine the mechanism underlying the phase variation of hemoglobin utilization by N. gonorrhoeae, we studied the expression and function of a 42-kDa outer membrane protein, HpuA, identified in the hemoglobin-utilizing variants of both FA19 and FA1090 grown under iron-stressed conditions. While hpuA was located immediately upstream from hpuB, the gene encoding the previously reported 89-kDa hemoglobin-binding outer membrane protein (8), we were unable to identify any consensus promoter sequence that might direct the transcription of hpuB within the short DNA fragment between the stop codon of hpuA and the start codon of hpuB. Polar insertional mutation of hpuA prevented production of both HpuA and HpuB. Thus, it is most likely that, in N. gonorrhoeae, hpuA and hpuB are comprised in a two-component operon similar to that in N. meningitidis (31).
Variation in the expression of gonococcal HpuA and HpuB was associated
with variation in the length of a run of G residues at the 5' end of
hpuA, located within the sequence encoding the N-terminal
amino acids for mature protein. The hemoglobin-utilizing variants
contained 10 G's, whereas the non-hemoglobin-utilizing variants
contained 9 G's (Fig. 1). When hpuA had only 9 G's, a stop
codon occurred immediately at the end of the poly(G) tract. In
Hgb+ variants, the 10-G poly(G) tract enabled a change of
the translational reading frame and thus the expression of HpuA and
HpuB. This apparently explains the high frequency (1 × 10
4 to 2 × 10
3) of spontaneous
Hgb
-to-Hgb+ variation observed in all tested
gonococcal strains (8). Other gonococcal phase-varying
systems include Pil (19, 36), PilC (25), Opa
(33, 48), and lipooligosaccharide (2). The mechanism for phase variation of HpuA and HpuB is similar to that for
Opa, PilC, and lipooligosaccharide in that each apparently uses
slipped-strand mispairing to alter the length of a short DNA repeat,
which affects translational frame and therefore expression (13,
18, 25, 39, 40).
Although we have been unable to develop a protocol to detect the on-phase-to-off-phase switch of hemoglobin utilization, it is likely that the postulated on-to-off switch also occurs at a relatively high frequency. It is unclear what advantage might be gained by phase variation and iron repression of hemoglobin-binding protein expression. We speculate, however, that phase variation of a hemoglobin-binding protein in gonococci would enable efficient utilization of menstrual hemoglobin. Recently, two genes encoding hemoglobin-binding proteins of Haemophilus influenzae (HgpA and HgpB) have been cloned (23, 24, 45). Regions of CCAA nucleotide-repeating units immediately following the putative leader cleavage site were identified in both hgpA and hgpB. It has been postulated that alteration of the reading frame across the CCAA region of hgpA or hgpB by strand slippage would lead to production of either protein (23). Thus, the heme-regulated expression of H. influenzae hemoglobin-binding proteins might very well be another example of phase variation of hemoglobin-binding proteins.
The gonococcal hpuA gene encodes a consensus signal
peptidase II cleavage site (21), suggesting that HpuA is
lipid modified. The difference between the observed molecular mass (42 kDa) and the calculated molecular mass (36 kDa) is consistent with
lipid modification of HpuA. The nonintegral membrane protein
characteristics of HpuA were demonstrated in membrane preparations of
the HpuA+ HpuB
mutant FA6929. In the absence
of the integral outer membrane protein HpuB, HpuA could not be detected
among Sarkosyl-resistant outer membrane proteins (Fig. 3B) or total
membrane proteins subjected to hemoglobin-agarose purification (Fig.
3C). On the other hand, the absence of HpuA had no obvious effect on
the hemoglobin binding ability of HpuB (Fig. 3C). It is possible that
the apparently decreased binding of FA6983 cells to biotinylated
hemoglobin (Fig. 4) was due to decreased production of HpuB instead of
impaired hemoglobin binding by HpuB (Fig. 3C).
We could not detect hemoglobin binding by HpuA alone in cell-free systems, but HpuA must play a critical role in the utilization of hemoglobin for growth. FA6983, the mutant which expressed HpuB but not HpuA, bound hemoglobin in affinity purification (Fig. 3C) but was unable to grow on media where hemoglobin was the sole source of iron (Fig. 5). Thus, HpuA and HpuB, while showing differences in their abilities to bind hemoglobin, were both required for hemoglobin utilization by gonococci.
Lee (26) reported isolation of two hemin-binding proteins (HmBPs) by affinity purification from gonococci grown under iron-limited conditions. These two HmBPs have observed molecular masses of 44 and 97 kDa, very close to the 42 and 89 kDa of HpuA and HpuB. HmBPs bound to hemin-agarose, and the binding was competitively inhibited by hemoglobin. Growth on hemoglobin was inhibited by a monoclonal antibody directed against the 97-kDa HmBP (26, 29). These results suggest that HmBPs might be identical to HpuA and HpuB. However, our results showed that neither HpuA nor HpuB was required for growth on hemin plates, and in whole-cell dot blot assays, hemoglobin binding by FA1090 Hgb+ was not affected by excess hemin. These are not the results that would be expected if HpuA and HpuB were identical to the HmBPs. In the current absence of sequence data for the HmBPs, and of specific mutants of the HmBPs, we cannot be certain that HpuA and HpuB are different from the HmBPs.
Gonococci possess multiple specific systems to acquire iron from different sources: transferrin and lactoferrin (4, 5, 11, 34), aerobactin (54), enterobactin (46), hemoglobin (38), and, undoubtedly, heme (14, 15, 27). This presumably reflects the differences in available iron at different body sites and under different physiological conditions (53). Acquisition of iron from transferrin, lactoferrin, and hemoglobin may involve a bipartite receptor system. The operon, tbpBA, encoding the outer membrane lipoprotein, TbpB, and the TonB-dependent outer membrane transferrin receptor, TbpA, has been well studied (1, 10, 11). It is also known that there is a gene for a lipoprotein homologous to tbpB in meningococci immediately upstream of lbpA, which encodes the TonB-dependent lactoferrin receptor LbpA (6, 7, 32, 43). Recently, a similar lipoprotein gene has been found in N. gonorrhoeae, immediately upstream of lbpA (3).
The HpuA-HpuB receptor system for utilization of hemoglobin in N. gonorrhoeae is similar in several respects to that of TbpB-TbpA. Gonococcal TbpB, a lipid-modified protein, binds to transferrin in
affinity purification but cannot be affinity purified from a
TbpA
mutant in the presence of the detergent Sarkosyl
(9). HpuA, the lipoprotein analogous to TbpB, was not
Sarkosyl resistant and could be affinity purified only in the presence
of HpuB, the integral outer membrane protein analogous to TbpA. This
could reflect a physical association between HpuA and HpuB, such as has
been proposed for TbpB and TbpA (12). In N. gonorrhoeae, a TbpB
mutant shows reduced binding of
transferrin but exhibits growth on transferrin plates; a
TbpA
mutant binds less transferrin and does not grow on
transferrin plates (1). In these respects, the gonococcal
TbpB-TbpA system does not correspond to what we have described for HpuA
and HpuB; however, in N. meningitidis, both
TbpB
and TbpA
mutants are unable to grow on
transferrin-bound iron (22), analogous to the results for
the gonococcal HpuA-HpuB system.
The importance of both HpuA and HpuB in gonococcal hemoglobin utilization has been demonstrated, but many questions remain to be answered concerning the exact function and location of HpuA and HpuB. A better understanding of how they interact to facilitate iron uptake from hemoglobin will be the aim of future work.
| |
ACKNOWLEDGMENTS |
|---|
We are thankful to William Shafer of Emory University for providing us with plasmid pUC18k. We thank members of the Sparling laboratory and Cynthia Cornelissen of Virginia Commonwealth University for helpful discussions and for critiquing the manuscript, Christopher Thomas for assistance in analyzing cloning and sequencing data, and Annice Rountree for her expert technical assistance.
This work was supported by Public Health Service grants AI31496 and AI26837 to P. Frederick Sparling. Ching-ju Chen was supported by institutional STD training grant AI07001.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7005. Phone: (919) 966-4468. Fax: (919) 966-5775. E-mail: zman{at}med.unc.edu.
Editor: P. E. Orndorff
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Anderson, J. E.,
P. F. Sparling, and C. N. Cornelissen.
1994.
Gonococcal transferrin-binding protein 2 facilitates but is not essential for transferrin utilization.
J. Bacteriol.
176:3162-3170 |
| 2. |
Apicella, M. A.,
M. Shero,
G. A. Jarvis,
J. M. Griffiss,
R. E. Mandrell, and H. Schneider.
1987.
Phenotypic variation in epitope expression of the Neisseria gonorrhoeae lipooligosaccharide.
Infect. Immun.
55:1755-1761 |
| 3. | Biswas, G., and P. F. Sparling. 1997. Personal communication. |
| 4. | Biswas, G. D., and P. F. Sparling. 1995. Characterization of lbpA, the structural gene for a lactoferrin receptor in Neisseria gonorrhoeae. Infect. Immun. 63:2958-2967[Abstract]. |
| 5. |
Blanton, K. J.,
G. D. Biswas,
J. Tsai,
J. Adams,
D. W. Dyer,
S. M. Davis,
G. G. Koch,
P. K. Sen, and P. F. Sparling.
1990.
Genetic evidence that Neisseria gonorrhoeae produces specific receptors for transferrin and lactoferrin.
J. Bacteriol.
172:5225-5235 |
| 6. | Bonnah, R. A., H. Wong, and A. B. Schryvers. 1996. , p. 206. Genetic and serological analysis of lactoferrin receptors in the Neisseria: evidence for the antigenically conserved nature of LbpB, abstr. p. 560. In W. Zollinger, C. Frasch, and C. Deal (ed.), Abstracts of the Tenth International Pathogenic Neisseria Conference. |
| 7. | Bonnah, R. A., R.-H. Yu, and A. B. Schryvers. 1995. Biochemical analysis of lactoferrin receptors in the Neisseriaceae: identification of a second bacterial lactoferrin receptor. Microb. Pathog. 19:285-297[Medline]. |
| 8. | Chen, C.-J., P. F. Sparling, L. A. Lewis, D. W. Dyer, and C. Elkins. 1996. Identification and purification of a hemoglobin-binding outer membrane protein from Neisseria gonorrhoeae. Infect. Immun. 64:5008-5014[Abstract]. |
| 9. |
Cornelissen, C., and P. F. Sparling.
1996.
Binding and surface exposure characteristics of the gonococcal transferrin receptor are dependent on both transferrin-binding proteins.
J. Bacteriol.
178:1437-1444 |
| 10. |
Cornelissen, C. N.,
G. D. Biswas,
J. Tsai,
D. K. Paruchuri,
S. A. Thompson, and P. F. Sparling.
1992.
Gonococcal transferrin-binding protein 1 is required for transferrin utilization and is homologous to TonB-dependent outer membrane receptors.
J. Bacteriol.
174:5788-5797 |
| 11. | Cornelissen, C. N., and P. F. Sparling. 1994. Iron piracy: acquisition of transferrin-bound iron by bacterial pathogens. Mol. Microbiol. 14:843-850[Medline]. |
| 12. | Cornelissen, C. N., J. E. Anderson, and P. F. Sparling. 1997. Energy-dependent changes in the gonococcal transferrin receptor. Mol. Microbiol. 26:25-35[Medline]. |
| 13. |
Danaher, R. J.,
J. C. Levin,
D. Arking,
C. L. Burch, and R. Sandlin.
1995.
Genetic basis of Neisseria gonorrhoeae lipooligosaccharide antigenic variation.
J. Bacteriol.
177:7275-7279 |
| 14. | Desai, P. J., R. Nzeribe, and C. A. Genco. 1995. Binding and accumulation of hemin in Neisseria gonorrhoeae. Infect. Immun. 63:4634-4641[Abstract]. |
| 15. |
Dyer, D. W.,
E. P. West, and P. F. Sparling.
1987.
Effects of serum carrier proteins on the growth of pathogenic Neisseriae with heme-bound iron.
Infect. Immun.
55:2171-2175 |
| 16. | Elkins, C. 1995. Identification and purification of a conserved heme-regulated hemoglobin-binding outer membrane protein from Haemophilus ducreyi. Infect. Immun. 63:1241-1245[Abstract]. |
| 17. | Elkins, C., N. H. Carbonetti, V. A. Varela, D. Stirewalt, D. G. Klapper, and P. F. Sparling. 1992. Antibodies to N-terminal peptides of gonococcal porin are bactericidal when gonococcal lipopolysaccharide is not sialylated. Mol. Microbiol. 6:2617-2628[Medline]. |
| 18. |
Gotschlich, E. C.
1994.
Genetic locus for the biosynthesis of the variable portion of Neisseria gonorrhoeae lipooligosaccharide.
J. Exp. Med.
180:2181-2190 |
| 19. | Hagblom, P., E. Segal, E. Billyard, and M. So. 1985. Intragenic recombination leads to pilus antigenic variation in Neisseria gonorrhoeae. Nature 315:156-158[Medline]. |
| 20. | Harlow, E., and D. Lane. 1988. . Antibodies: a laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y. |
| 21. | Hayashi, S., and H. C. Wu. 1990. Lipoprotein in Bacteria. J. Bioenerg. Biomembr. 22:451-471[Medline]. |
| 22. | Irwin, S. W., C. Y. Averil, C. Y. Cheng, and A. B. Schryvers. 1993. Preparation and analysis of isogenic mutants in the transferrin receptor protein genes, tbpA and tbpB, from Neisseria meningitidis. Mol. Microbiol. 8:1125-1133[Medline]. |
| 23. | Jin, H., Z. Ren, J. M. Pozsgay, C. Elkins, P. W. Whitby, D. J. Morton, and T. L. Stull. 1996. Cloning of a DNA fragment encoding a heme-repressible hemoglobin-binding protein outer membrane protein from Haemophilus influenzae. Infect. Immun. 64:3134-3141[Abstract]. |
| 24. | Jin, H., Z. Ren, P. W. Whitby, D. J. Morton, and T. L. Stull. 1997. Genetic analysis of a hemoglobin binding protein (HgpA) of Haemophilus influenzae, abstr. B-223, p. 67. Abstracts of the 97th General Meeting of the American Society for Microbiology. American Society for Microbiology, Washington, D.C. |
| 25. | Jonsson, A. B., G. Nyberg, and S. Normark. 1991. Phase variation of gonococcal pili by frameshift mutation in pilC, a novel gene for pilus assembly. EMBO J. 10:477-488[Medline]. |
| 26. | Lee, B. C. 1992. Isolation of haemin-binding proteins of Neisseria gonorrhoeae. J. Med. Microbiol. 36:121-127[Abstract]. |
| 27. | Lee, B. C. 1995. Quelling the red menace: haem capture by bacteria. Mol. Microbiol. 18:383-390[Medline]. |
| 28. | Lee, B. C., and P. Hill. 1992. Identification of an outer-membrane haemoglobin-binding protein in Neisseria meningitidis. J. Gen. Microbiol. 138:2647-2656[Medline]. |
| 29. | Lee, B. C., and S. Levesque. 1997. A monoclonal antibody directed against the 97-kilodalton gonococcal hemin-binding protein inhibits hemin utilization by Neisseria gonorrhoeae. Infect. Immun. 65:2970-2974[Abstract]. |
| 30. |
Lewis, L. A., and D. W. Dyer.
1995.
Identification of an iron-regulated outer membrane protein of Neisseria gonorrhoeae involved in the utilization of hemoglobin complexed to haptoglobin.
J. Bacteriol.
177:1299-1306 |
| 31. | Lewis, L. A., E. Gray, Y.-P. Wang, B. A. Roe, and D. W. Dyer. 1997. Molecular characterization of hpuAB, the haemoglobin-haptoglobin-utilization operon of Neisseria meningitidis. Mol. Microbiol. 23:737-749[Medline]. |
| 32. | Lewis, L. A., K. H. Rohde, B. Behrens, E. Gray, S. I. Toth, B. A. Roe, and D. W. Dyer. 1996. Molecular analysis of lbpAB encoding the two-component meningococcal lactoferrin receptor, abstr. P-214, p. 557. In W. Zollinger, C. Frasch, and C. Deal (ed.), Abstracts of the Tenth International Pathogenic Neisseria Conference . |
| 33. |
Mayer, L. W.
1982.
Rates of in vitro changes in gonococcal colony opacity phenotypes.
Infect. Immun.
37:481-485 |
| 34. |
McKenna, W. R.,
P. A. Mickelsen,
P. F. Sparling, and D. W. Dyer.
1988.
Iron uptake from lactoferrin and transferrin by Neisseria gonorrhoeae.
Infect. Immun.
56:785-791 |
| 35. |
Ménard, R.,
P. J. Sansonetti, and C. Parsot.
1993.
Nonpolar mutagenesis of the ipa genes defines IpaB, IpaC, and IpaD as effectors of Shigella flexneri entry into epithelial cells.
J. Bacteriol.
175:5899-5906 |
| 36. | Meyer, T. F., N. Mlawer, and M. So. 1982. Pilus expression in Neisseria gonorrhoeae involves chromosomal rearrangement. Cell 30:45-52[Medline]. |
| 37. |
Mickelsen, P. A.,
E. Blackman, and P. F. Sparling.
1982.
Ability of Neisseria gonorrhoeae, Neisseria meningitidis, and commensal Neisseria species to obtain iron from lactoferrin.
Infect. Immun.
35:915-920 |
| 38. |
Mickelsen, P. A., and P. F. Sparling.
1981.
Ability of Neisseria gonorrhoeae, Neisseria meningitidis, and commensal Neisseria species to obtain iron from transferrin and iron compounds.
Infect. Immun.
33:555-564 |
| 39. | Muralidharan, K., A. Stern, and T. F. Meyer. 1987. The control mechanism of opacity protein expression in the pathogenic Neisseriae. Antonie Leeuwenhoek 53:435-440. |
| 40. | Murphy, G. L., T. D. Connell, D. S. Barritt, M. Koomey, and J. G. Cannon. 1989. Phase variation of gonococcal protein II: regulation of gene expression by slipped-strand mispairing of a repetitive DNA sequence. Cell 56:539-547[Medline]. |
| 41. | Nachamkin, I., J. G. Cannon, and R. S. Mittler. 1981. Monoclonal antibodies against Neisseria gonorrhoeae: production of antibodies directed against a strain-specific cell surface antigen. Infect. Immun. 33:555-564. |
| 42. | Parekh, B. S., P. W. Schwimmbeck, and M. J. Buchmeier. 1989. High efficiency immunoaffinity purification of antipeptide antibodies on thiopropyl Sepharose immunoadsorbents. Peptide Res. 2:249-253. |
| 43. | Petterson, A., T. Prinz, P. van der Ley, J. T. Poolman, and J. Tommassen. 1996. Characterization of the meningococcal lactoferrin receptor, abstr. P-221, p. 587. In W. Zollinger, C. Frasch, and C. Deal (ed.), Abstracts of the Tenth International Pathogenic Neisseria Conference . |
| 44. | Prentki, P., and H. M. Krisch. 1984. In vitro insertional mutagenesis with a selectable DNA fragment. Gene 29:303-313[Medline]. |
| 45. | Ren, Z., H. Jin, D. J. Morton, and T. L. Stull. 1997. Cloning of hgpB, a gene encoding a second hemoglobin binding protein of Haemophilus influenzae, abstr. B-227, p. 67. Abstracts of the 97th General Meeting of the American Society for Microbiology. American Society for Microbiology, Washington, D.C. |
| 46. |
Rutz, J. M.,
T. Abdullah,
S. P. Singh,
V. I. Kalve, and P. E. Klebba.
1991.
Evolution of the ferric enterobactin receptor in gram-negative bacteria.
J. Bacteriol.
173:5964-5974 |
| 47. | Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. . Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y. |
| 48. | Stern, A., M. Brown, P. Nickel, and T. F. Meyer. 1986. Opacity genes in Neisseria gonorrhoeae: control of phase and antigenic variation. Cell 47:61-71[Medline]. |
| 49. | Stojiljkovic, I., V. Hwa, S. L. de Martin, P. O'Gaora, X. Nassif, F. Heffon, and M. So. 1995. The Neisseria meningitidis hemoglobin receptor: its role in iron utilization and virulence. Mol. Microbiol. 15:531-541[Medline]. |
| 50. |
Stojiljkovic, I.,
J. Larson,
V. Hwa,
S. Anic, and M. So.
1996.
HmbR outer membrane receptors of pathogenic Neisseria spp.: iron-regulated, hemoglobin-binding proteins with a high level of primary structure conservation.
J. Bacteriol.
178:4670-4678 |
| 51. | Tsai, C. M., and C. E. Frasch. 1982. A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels. Anal. Biochem. 119:115-119[Medline]. |
| 52. |
Weinberg, E. D.
1978.
Iron and infection.
Microbiol. Rev.
42:45-66 |
| 53. |
West, S. E. H., and P. F. Sparling.
1985.
Response of Neisseria gonorrhoeae to iron limitation: alterations in expression of membrane proteins without apparent siderophore production.
Infect. Immun.
47:388-394 |
| 54. |
West, S. E. H., and P. F. Sparling.
1987.
Aerobactin utilization by Neisseria gonorrhoeae and cloning of a genomic DNA fragment that complements Escherichia coli fhuB mutations.
J. Bacteriol.
169:3414-3421 |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|